Donation of placenta to collect mitochondria for future mitochondrial augmentation therapies
Official title: Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies
Run by Minovia Therapeutics Ltd. · NCT03762512 · Data updated 2026-11-12
This project collects placentas donated by healthy women having elective C-section deliveries so mitochondria can be harvested for possible future mitochondrial augmentation therapies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Minovia Therapeutics Ltd. Industry-sponsored |
| Locations | 1 site (Ramat Gan) |
| Status | Recruiting |
| Started | December 1, 2018 |
| Main results expected | December 2027 |
| Study ends | March 2028 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT03762512 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy pregnant women aged 18–45 planning an elective C-section at 36–41 weeks with an uncomplicated pregnancy and available medical history.
✕Probably not a fit
Women who are positive or at risk for communicable diseases, have complicated pregnancies, heavy tobacco or alcohol use, or who do not plan an elective C-section are unlikely to qualify or benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program enrolls healthy pregnant women aged 18–45 who plan an elective C-section between 36 and 41 weeks and who have uncomplicated pregnancies. Donated placentas are screened for infectious risks and relevant medical history before collection. Mitochondria are isolated from collected placentas and stored for research and potential future therapeutic use. There is no intervention to the donor beyond consent and standard delivery care.
Why it matters
Potential benefit: If successful, the collected mitochondria could support development of mitochondrial augmentation therapies that may help people with mitochondrial disorders.
How similar studies have gone: Related approaches to mitochondrial isolation and augmentation have shown promise in preclinical work and very early human studies, but broad clinical benefit remains unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Healthy pregnant females between the age of 18-45, judged to be medically eligible by the Investigator and the Sponsor's Medical Monitor. 2. Planned elective C-section at weeks 36-41 of pregnancy. 3. Uncomplicated pregnancy as determined by the Investigator. 4. Available Medical History of the donor (diagnosis, diseases, medication etc…) Exclusion Criteria: 1. Donor is positive for a communicable disease, such as: HBV, HCV, HIV 1\&2, WNV, HTLV 1\&2, Treponema pallidum, CMV, Chagas, Chlamydia Trachomatis, Neisseria Gonorrhea, or any other tests required by the medical facility, IMoH, FDA, EMA or the Sponsor. 2. Donor is at risk for a communicable disease as assessed by medical history, medical records, physical exam, and the Donor Screening Questionnaire. 3. Donor is at risk for COVID-19 as assessed by medical history, medical records, physical exam, and the COVID-19 Screening Questionnaire. 4. Donor smokes more than one pack of cigarettes a day or drinks more than one alcoholic beverage a day. 5. Donor has taken a medication with potential mitochondrial effects within 2 weeks prior to placental donation, such as valproic acid, aminoglycoside antibiotics, neuromuscular blocking drugs (See Appendix 3). 6. Donor has current or history of malignancy. 7. Donor has current or history of insulin dependent diabetes 8. Donor has current gestational diabetes treated with insulin, or pre-eclampsia. 9. Donor is known to be a carrier of a primary mitochondrial disease.
Where it's running
-
Sheba Medical Center Hospital- Tel Hashomer
Ramat Gan, Israel Recruiting
Study contacts
- Study coordinator: Klari Uziel
- Email: klariuz@clalit.org.il
- Phone: +972544817280
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Lower-extremity blood pressure monitoring during cesarean under spinal anesthesia
This study tests whether noninvasive blood pressure monitoring from the toe is better than the arm at predicting neonatal outcomes during cesarean delivery with spinal anesthesia.
-
Care4mommies: a compassion-based approach to support moms-to-be
A compassion-based program with pregnancy-specific content is being tested to see if it helps pregnant people build self-compassion and strengthen the bond with their baby.
-
Eating more eggs during pregnancy to support fetal brain development
This test will see if pregnant women who eat 10–14 eggs per week have better fetal brain development than those who follow a general healthy prenatal diet.
-
See if extra prenatal breastfeeding education helps moms in Inland Empire breastfeed exclusively
This study tests whether supplemental breastfeeding education during pregnancy increases exclusive breastfeeding at 6 weeks after birth for first-time moms or those who didn’t breastfeed long in the past.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.